Laetitia leads our efforts on vaccines policy and advocacy to encourage pharmaceutical innovation and improve people’s health and well-being around the world.
She oversees the Vaccines Committee, the interface between IFPMA members and international public health organizations involved in global immunization, which promotes sustainable policies and initiatives to support vaccine innovation and access to vaccines globally.
Prior to joining IFPMA, Laetitia worked as a clinical research associate for the multidisciplinary center on oncology at the University Hospital Lausanne.
She has a PhD in Molecular Biology from the University of Lausanne, Switzerland.
The COVID-19 pandemic has shown that, when we work together, we can achieve more than we ever thought possible. Together, we can give vaccines the greatest chance to make an even greater impact on our health, our communities, and our world.
More from Laetitia
How will vaccines save us from future threats?
The groundbreaking work of Professors Katalin Karikó and Drew Weissman was recently recognized, as they were awarded this year’s Nobel Prize in Physiology and Medicine. Their award was recognition for the research that ultimately enabled the development of safe and effective mRNA vaccines against COVID-19, and which has now spurred further research into how the...
Read moreWhy vaccines and continued vaccine innovation matter today and for the future?
Every year during World Immunization Week we take the time to celebrate the impact of vaccines, but this year there is heightened concern and apprehension around the status of vaccination programs around the world. The big catch-up year Recent pandemic disruptions to health and education systems have led to significant drops in childhood vaccination numbers,...
Read moreImproving child health around the world through immunisation
Ever since the smallpox vaccine discovery over two centuries ago, vaccines have successfully worked to eradicate, eliminate, or control many infectious diseases.
Read more